Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

[Influence of diagnostic pathway on clinical and non-conventional therapies use in women with breast cancer of the cohort DAMA].

Torá-Rocamora I, Grau J, Oliver-Vall-Llosera B, Bargalló X, Aldea M, Puigpinós-Riera R; grupo Cohorte DAMA.

Gac Sanit. 2019 Apr 15. pii: S0213-9111(19)30078-0. doi: 10.1016/j.gaceta.2019.02.006. [Epub ahead of print] Spanish.

2.

Impact of a Primary Care intervention on the colorectal cancer early detection programme.

Luque Mellado FJ, Paino Pardal L, Condomines Feliu I, Tora-Rocamora I, Cuadras Rofastes M, Romero Díaz E, Pacheco Ortiz M, Camuñez Bravo JC, Aldea M, Grau Cano J; grupo de investigación PROCOLON.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):351-361. doi: 10.1016/j.gastrohep.2019.01.007. Epub 2019 Apr 4. English, Spanish.

PMID:
30954319
3.

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.

Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X.

Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10.

PMID:
30544059
4.

Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.

Sala M, Domingo L, Louro J, Torá-Rocamora I, Baré M, Ferrer J, Carmona-Garcia MC, Barata T, Román M, Macià F, Castells X; CAMISS Study Group.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):908-916. doi: 10.1158/1055-9965.EPI-17-0995. Epub 2018 May 31.

PMID:
29853482
5.

Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.

Román M, Caicoya M, Espinàs J, Sala M, Torá-Rocamora I, Quinta MJ, Vernet M, Saladié F, Romero A, Sánchez M, Baré M, Vidal C, Servitja S, Natal C, Corominas J, Ferrer J, Rodríguez-Arana A, Castells X; BELE Project study group.

Breast J. 2018 Jul;24(4):509-518. doi: 10.1111/tbj.13003. Epub 2018 Mar 8.

PMID:
29517151
6.

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.

Posso M, Corominas JM, Serrano L, Román M, Torá-Rocamora I, Domingo L, Romero A, Quintana MJ, Vernet-Tomas M, Baré M, Vidal C, Sánchez M, Saladié F, Natal C, Ferrer J, Servitja S, Sala M, Castells X; BELE Study Group.

Cancer Med. 2017 Jun;6(6):1482-1489. doi: 10.1002/cam4.1080. Epub 2017 May 4.

7.

Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs.

Romero A, Torà-Rocamora I, Baré M, Barata T, Domingo L, Ferrer J, Torà N, Comas M, Merenciano C, Macià F, Castells X, Sala M; CAMISS Study Group.

BMC Cancer. 2016 Sep 15;16(1):735. doi: 10.1186/s12885-016-2768-1.

8.

Gender differences in the duration of non-work-related sickness absence episodes due to musculoskeletal disorders.

Arcas MM, Delclos GL, Torá-Rocamora I, Martínez JM, Benavides FG.

J Epidemiol Community Health. 2016 Nov;70(11):1065-1073. doi: 10.1136/jech-2014-204331. Epub 2016 May 13.

PMID:
27177580
9.

[Variations in the diagnostic confirmation process between breast cancer mass screening units].

Natal C, Fernández-Somoano A, Torá-Rocamora I, Tardón A, Castells X; en nombre del grupo BELE.

Gac Sanit. 2016 Jul-Aug;30(4):265-71. doi: 10.1016/j.gaceta.2016.03.005. Epub 2016 Apr 29. Spanish.

10.

Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.

Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M; BELE Study Group.

Radiology. 2016 Aug;280(2):379-86. doi: 10.1148/radiol.2016151174. Epub 2016 Feb 15.

PMID:
26878225
11.

Assessment of the magnitude of geographical variations in the duration of non-work-related sickness absence by individual and contextual factors.

Torá-Rocamora I, Martínez JM, Gimeno D, Alberti C, Jardí J, Manzanera R, Benavides FG, Delclos G.

Gac Sanit. 2015 May-Jun;29(3):164-71. doi: 10.1016/j.gaceta.2014.12.004. Epub 2015 Jan 28.

12.

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.

Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M.

Breast Cancer Res Treat. 2015 Jan;149(1):237-44. doi: 10.1007/s10549-014-3208-z. Epub 2014 Dec 13.

13.

Heterogeneity and event dependence in the analysis of sickness absence.

Torá-Rocamora I, Gimeno D, Delclos G, Benavides FG, Manzanera R, Jardí J, Alberti C, Yasui Y, Martínez JM.

BMC Med Res Methodol. 2013 Sep 16;13:114. doi: 10.1186/1471-2288-13-114.

14.

Occupational health impact of the 2009 H1N1 flu pandemic: surveillance of sickness absence.

Torá-Rocamora I, Delclos GL, Martínez JM, Jardí J, Alberti C, Manzanera R, Yasui Y, Clèries R, Tobías A, Benavides FG.

Occup Environ Med. 2012 Mar;69(3):205-10. doi: 10.1136/oem.2011.065003. Epub 2011 Jun 14.

PMID:
21676949
15.

[Duration of work absence attributable to non work-related diseases by health regions in catalonia].

Torá Rocamora I, Martínez Martínez JM, Delclos Clanchet J, Jardí Lliberia J, Alberti Casas C, Serra Pujadas C, Manzanera López R, Benavides FG.

Rev Esp Salud Publica. 2010 Jan-Feb;84(1):61-9. Spanish.

Supplemental Content

Loading ...
Support Center